ProScript, Roche deal

The companies agreed to discover and develop compounds to treat cachexia (muscle wasting), with an initial focus on cancer. Using ProScript's cachexia-specific assays, the companies hope to intervene in the "ubiquitination cascade," an intracellular biochemical pathway that is up-regulated in disease. ...